Lessons from randomized phase III studies with active cancer immunotherapies–outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC)
LH Finke, K Wentworth, B Blumenstein, NS Rudolph… - Vaccine, 2007 - Elsevier
After years of effort to develop active cancer immunotherapies, seven candidate products
achieved promising results in phase I/II studies that triggered phase III randomized studies …
achieved promising results in phase I/II studies that triggered phase III randomized studies …
Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC)
LH Finke, K Wentworth, B Blumenstein… - …, 2007 - pubmed.ncbi.nlm.nih.gov
After years of effort to develop active cancer immunotherapies, seven candidate products
achieved promising results in phase I/II studies that triggered phase III randomized studies …
achieved promising results in phase I/II studies that triggered phase III randomized studies …
Lessons from randomized phase III studies with active cancer immunotherapies-Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)
LH Finke, K Wentworth, B Blumenstein… - Vaccine, 2007 - pure.johnshopkins.edu
After years of effort to develop active cancer immunotherapies, seven candidate products
achieved promising results in phase I/II studies that triggered phase III randomized studies …
achieved promising results in phase I/II studies that triggered phase III randomized studies …
Lessons from randomized phase III studies with active cancer immunotherapies–Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)
LH Finke, K Wentworth, B Blumenstein, NS Rudolph… - Vaccine, 2007 - infona.pl
After years of effort to develop active cancer immunotherapies, seven candidate products
achieved promising results in phase I/II studies that triggered phase III randomized studies …
achieved promising results in phase I/II studies that triggered phase III randomized studies …
[PDF][PDF] Lessons from randomized phase III studies with active cancer immunotherapies–Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)
LH Finkea, K Wentworthb, B Blumensteinc… - Vaccine, 2007 - academia.edu
After years of effort to develop active cancer immunotherapies, seven candidate products
achieved promising results in phase I/II studies that triggered phase III randomized studies …
achieved promising results in phase I/II studies that triggered phase III randomized studies …
[引用][C] Lessons from randomized phase III studies with active cancer immunotherapies–Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)
LH Finke, K Wentworth, B Blumenstein, NS Rudolph… - Vaccine, 2007 - cir.nii.ac.jp
Lessons from randomized phase III studies with active cancer immunotherapies – Outcomes
from the 2006 Meeting of the Cancer Vaccine Consortium (CVC) | CiNii Research CiNii 国立 …
from the 2006 Meeting of the Cancer Vaccine Consortium (CVC) | CiNii Research CiNii 国立 …
[引用][C] Lessons from randomized phase III studies with active cancer immunotherapies-Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)
LH FINKE, K WENTWORTH… - Vaccine …, 2007 - pascal-francis.inist.fr
Lessons from randomized phase III studies with active cancer immunotherapies -Outcomes from
the 2006 Meeting of the Cancer Vaccine Consortium (CVC) CNRS Inist Pascal-Francis CNRS …
the 2006 Meeting of the Cancer Vaccine Consortium (CVC) CNRS Inist Pascal-Francis CNRS …
Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).
LH Finke, K Wentworth, B Blumenstein, NS Rudolph… - Vaccine, 2007 - europepmc.org
After years of effort to develop active cancer immunotherapies, seven candidate products
achieved promising results in phase I/II studies that triggered phase III randomized studies …
achieved promising results in phase I/II studies that triggered phase III randomized studies …
[PDF][PDF] Lessons from randomized phase III studies with active cancer immunotherapies–Outcomes from the 2006 Meeting of the Cancer Vaccine Consortium (CVC)
LH Finkea, K Wentworthb, B Blumensteinc… - Vaccine, 2007 - academia.edu
After years of effort to develop active cancer immunotherapies, seven candidate products
achieved promising results in phase I/II studies that triggered phase III randomized studies …
achieved promising results in phase I/II studies that triggered phase III randomized studies …
[引用][C] Lessons from randomized phase III studies with active cancer immunotherapies-outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC)
LH FINKE - Vaccine, 2007 - cir.nii.ac.jp
Lessons from randomized phase III studies with active cancer immunotherapies-outcomes from
the 2006 meeting of the Cancer Vaccine Consortium (CVC) | CiNii Research CiNii 国立情報学 …
the 2006 meeting of the Cancer Vaccine Consortium (CVC) | CiNii Research CiNii 国立情報学 …